IPOs

Novalis LifeSciences Launches its First Life Science Investment Fund with $85 Million
Novalis LifeSciences Launches its First Life Science Investment Fund with $85 Million
CP Wire
Novalis LIfeSciences
IPOs
Flag link:
10X Genomics Files for $100 Million IPO
10X Genomics Files for $100 Million IPO
CP Wire
10X Gennomics
genomics
IPOs
Flag link:
IGM Biosciences files for $100 Million IPO
IGM Biosciences files for $100 Million IPO
CP Wire
IGM Biosciences
IPOs
antibodies
cancer
Flag link:
IGM Biosciences files for $100 Million IPO
IGM Biosciences
IPOs
Flag link:
Pfizer Spinout SpringWorks, Migraine Drug Firm Satsuma Prep IPOs
Pfizer Spinout SpringWorks, Migraine Drug Firm Satsuma Prep IPOs
Xconomy
IPOs
SpringWorks Therapeutics
Pfizer
Satsuma Pharmaceuticals
Flag link:
Smile Direct Club Files for $100 Million IPO
Smile Direct Club Files for $100 Million IPO
CP Wire
Smile Direct Club
IPOs
orthodontic
dental health
Flag link:
Analysts track doubling in number of private biotech rounds
Analysts track doubling in number of private biotech rounds
Fierce Biotech
biotech
IPOs
Flag link:
RAPT Therapeutics Postpones $86 Million IPO
RAPT Therapeutics Postpones $86 Million IPO
BioSpace
RAPT Therapeutics
IPOs
Flag link:
As Castle Bio Jumps on IPO Train, Industry Trends Suggest Slowdown
As Castle Bio Jumps on IPO Train, Industry Trends Suggest Slowdown
Xconomy
Castle Biosciences
IPOs
diagnostics
Flag link:
2 Small-Cap Biotech IPOs You Should Know About
2 Small-Cap Biotech IPOs You Should Know About
Motley Fool
Personalis
NextCure
IPOs
Flag link:
Denmark's Genmab hits the jackpot with $500M+ US IPO as smaller biotechs rake in a combined $147M
Denmark's Genmab hits the jackpot with $500M+ US IPO as smaller biotechs rake in a combined $147M
Endpoints
Genmab
IPOs
cancer
Flag link:
Only Days After Hinting at an IPO, PureTech Acquires Lymphedema Asset
Only Days After Hinting at an IPO, PureTech Acquires Lymphedema Asset
BioSpace
Pure Tech Health
IPOs
LYT-100
lymphedema
Flag link:
HitGen joins growing Shanghai IPO queue
HitGen joins growing Shanghai IPO queue
BioCentury
HitGen
IPOs
China
Shanghai
Flag link:
Genmab steps up for a $500M IPO haul, with its sights on a record-setting market cap
Genmab steps up for a $500M IPO haul, with its sights on a record-setting market cap
Endpoints
Genmab
IPOs
NASDAQ
Flag link:
RAPT Therapeutics Files For $86 Million IPO
RAPT Therapeutics Files For $86 Million IPO
CP Wire
APT Therapeutics
immuno-oncology
IPOs
Flag link:
RAPT Therapeutics Files For $86 Million IPO
RAPT Therapeutics
immuno-oncology
IPOs
Flag link:
Back to business for biotech flotations
Back to business for biotech flotations
EP Vantage
IPOs
BridgeBio
Turning Point Therapeutics
Stoke Therapeutics
Prevail Therapeutics
Atreca
NGM Biopharmaceuticals
Akero Therapeutics
Milestone Pharmaceuticals
Morphic Therapeutics
Karuna
Flag link:
Puretech-backed Karuna makes Nasdaq debut with $89M IPO
Puretech-backed Karuna makes Nasdaq debut with $89M IPO
Endpoints
Karuna
IPOs
NASDAQ
PureTech
Flag link:
Livongo Health Files for $100 Million IPO
Livongo Health Files for $100 Million IPO
CP Wire
Livongo Health
IPOs
digital health
Flag link:
Livongo Health Files for $100 Million IPO
Livongo
IPOs
Flag link:

Pages